Biogen
(NASDAQ) BIIB
Biogen Financials at a Glance
Market Cap
$30.20B
Revenue (TTM)
$9.86B
Net Income (TTM)
$1.37B
EPS (TTM)
$9.32
P/E Ratio
21.95
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$191.33
Volume
2,809,119.261
Open
$200.25
Price
$191.33
Volume
2,809,119.261
Open
$200.25
Previous Close
$191.37
Daily Range
$189.49 - $205.00
52-Week Range
$119.18 - $205.97
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$191.33
Volume
2,809,119.261
Open
$200.25
Previous Close
$191.37
Daily Range
$189.49 - $205.00
52-Week Range
$119.18 - $205.97
BIIB News
BIIB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biogen
Industry
Biotechnology
Sector
Health CareEmployees
7,500
CEO
Christopher A. Viehbacher, CPA
Website
www.biogen.comHeadquarters
Cambridge, MA 02142, US
BIIB Financials
Key Financial Metrics (TTM)
Gross Margin
70%
Operating Margin
16%
Net Income Margin
14%
Return on Equity
8%
Return on Capital
6%
Return on Assets
5%
Earnings Yield
4.56%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$30.20B
Shares Outstanding
147.64M
Volume
2.81M
Avg. Volume
1.11M
Financials (TTM)
Gross Profit
$6.91B
Operating Income
$1.88B
EBITDA
$3.10B
Operating Cash Flow
$2.20B
Capital Expenditure
$153.80M
Free Cash Flow
$2.05B
Cash & ST Invst.
$3.82B
Total Debt
$6.95B
Biogen Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.48B
+1.9%
Gross Profit
$1.82B
-2.0%
Gross Margin
73.32%
N/A
Market Cap
$30.20B
N/A
Market Cap/Employee
$3.97M
N/A
Employees
7,605
N/A
Net Income
$319.50M
+32.8%
EBITDA
$553.60M
-36.0%
Quarterly Fundamentals
Net Cash
$2.28B
+43.3%
Accounts Receivable
$1.79B
-10.3%
Inventory
$1.95B
-14.3%
Long Term Debt
$6.56B
+34.7%
Short Term Debt
$0.00
-100.0%
Return on Assets
4.65%
N/A
Return on Invested Capital
5.82%
N/A
Free Cash Flow
$696.70M
+228.3%
Operating Cash Flow
$645.50M
+148.9%